Details for New Drug Application (NDA): 205983
✉ Email this page to a colleague
The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Summary for 205983
Tradename: | QUETIAPINE FUMARATE |
Applicant: | Ipca Labs Ltd |
Ingredient: | quetiapine fumarate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205983
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | May 20, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | May 20, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | May 20, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription